AXL inhibition as a novel treatment of aggressive disease Short presentations will be given by our investigators and AXL KOLs in a relaxed atmosphere. Presentations will be made available in the investors section following the event. For further details and to receive an invitation please contact: firstname.lastname@example.org ASCO Personal Invitation
Contact us >
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.